Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
2019-20 coronavirus outbreak
Protocol design
Betacoronavirus
Pandemic
Coronavirus Infections
DOI:
10.1371/journal.pone.0286297
Publication Date:
2023-06-24T06:33:58Z
AUTHORS (204)
ABSTRACT
Importance SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms other health effects after the acute phase of infection; termed post-acute sequelae (PASC), long COVID. The characteristics, prevalence, trajectory and mechanisms PASC are ill-defined. objectives Researching COVID to Enhance Recovery (RECOVER) Multi-site Observational Study Adults (RECOVER-Adult) to: (1) characterize prevalence; (2) symptoms, organ dysfunction, natural history, distinct phenotypes PASC; (3) identify demographic, social clinical risk factors for onset recovery; (4) define biological underlying pathogenesis. Methods RECOVER-Adult is a combined prospective/retrospective cohort currently planned enroll 14,880 adults aged ≥18 years. Eligible participants either must meet WHO criteria suspected, probable, confirmed have evidence no prior infection. Recruitment occurs at 86 sites 33 U.S. states, Washington, DC Puerto Rico, via facility- community-based outreach. Participants complete quarterly questionnaires about determinants, vaccination status, interim infections. In addition, contribute biospecimens undergo physical laboratory examinations approximately 0, 90 180 days from negative test date, yearly thereafter. Some additional testing based on specific random sampling. Patient representatives provide input all study processes. primary outcome PASC, measured by signs symptoms. A paradigm identifying cases will be defined updated using supervised unsupervised learning approaches with cross-validation. Logistic regression proportional hazards conducted investigate associations between factors, onset, resolution Discussion first national, prospective, longitudinal among US adults. Results this intended inform public health, spur trials, expand treatment options. Registration NCT05172024 .
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (28)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....